Literature DB >> 23303663

Maternal attitudes to newborn screening for fragile X syndrome.

Louise Christie1, Tiffany Wotton, Bruce Bennetts, Veronica Wiley, Bridget Wilcken, Carolyn Rogers, Jackie Boyle, Catherine Turner, Jessica Hansen, Matthew Hunter, Himanshu Goel, Michael Field.   

Abstract

Although fragile X syndrome (FXS) is the commonest cause of inherited intellectual disability the mean age of diagnosis in Australia is 5.5 years. Newborn screening for FXS can provide an early diagnosis, preventing the "diagnostic odyssey", allowing access to early interventions, and providing reproductive information for parents. Parents of affected children support newborn screening, but few clinical studies have evaluated community attitudes. A pilot study in 2009-2010 was performed in a tertiary hospital to explore feasibility and maternal attitudes. FXS testing of male and female newborns was offered to mothers in addition to routine newborn screening. Mothers were provided with information about FXS, inheritance pattern, carrier status, and associated adult-onset disorders. One thousand nine hundred seventy-one of 2,094 mothers (94%) consented to testing of 2,000 newborns. 86% completed the attitudinal survey and 10% provided written comments. Almost all parents (99%) elected to be informed of both premutation and full mutation status and there was little concern about identification of carrier status or associated adult-onset disorders. Most mothers (96%) were comfortable being approached in the postnatal period and supported testing because no extra blood test was required. Mothers considered an early diagnosis beneficial to help prepare for a child with additional needs (93%) and for reproductive planning (64%). Some were anxious about the potential test results (10%) and others felt their feelings towards their newborn may change if diagnosed with FXS (16%). High participation rates and maternal attitudes indicate a high level of maternal acceptance and voluntary support for newborn screening for FXS.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23303663     DOI: 10.1002/ajmg.a.35752

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  10 in total

1.  High acceptance of an early dyslexia screening test involving genetic analyses in Germany.

Authors:  Arndt Wilcke; Bent Müller; Gesa Schaadt; Holger Kirsten; Johannes Boltze
Journal:  Eur J Hum Genet       Date:  2015-06-03       Impact factor: 4.246

2.  Biobank participant support of newborn screening for disorders with variable treatment and intervention options.

Authors:  Megan E Bunnell; Beth A Tarini; Michael Petros; Aaron J Goldenberg; Aishwarya Arjunan; Catherine Wicklund
Journal:  J Community Genet       Date:  2016-09-01

Review 3.  Newborn screening for fragile X syndrome.

Authors:  Flora Tassone
Journal:  JAMA Neurol       Date:  2014-03       Impact factor: 18.302

4.  Maternal Consequences of the Detection of Fragile X Carriers in Newborn Screening.

Authors:  Donald B Bailey; Anne Wheeler; Elizabeth Berry-Kravis; Randi Hagerman; Flora Tassone; Cynthia M Powell; Myra Roche; Louise W Gane; John Sideris
Journal:  Pediatrics       Date:  2015-07-13       Impact factor: 7.124

5.  Parental intentions to enroll children in a voluntary expanded newborn screening program.

Authors:  Ryan S Paquin; Holly L Peay; Lisa M Gehtland; Megan A Lewis; Donald B Bailey
Journal:  Soc Sci Med       Date:  2016-07-29       Impact factor: 4.634

6.  Identification of a male with fragile X syndrome through newborn screening.

Authors:  Jessica Famula; Kirin Basuta; Louise W Gane; Randi J Hagerman; Flora Tassone
Journal:  Intractable Rare Dis Res       Date:  2015-11

7.  Fragile X protein in newborn dried blood spots.

Authors:  Tatyana Adayev; Giuseppe LaFauci; Carl Dobkin; Michele Caggana; Veronica Wiley; Michael Field; Tiffany Wotton; Richard Kascsak; Sarah L Nolin; Anne Glicksman; Nicole Hosmer; W Ted Brown
Journal:  BMC Med Genet       Date:  2014-10-28       Impact factor: 2.103

Review 8.  Molecular Correlates and Recent Advancements in the Diagnosis and Screening of FMR1-Related Disorders.

Authors:  Indhu-Shree Rajan-Babu; Samuel S Chong
Journal:  Genes (Basel)       Date:  2016-10-14       Impact factor: 4.096

9.  Assessment of the Knowledge and Attitudes of Saudi Mothers towards Newborn Screening.

Authors:  Ayman Al-Sulaiman; Altaf A Kondkar; Mohammad Y Saeedi; Amal Saadallah; Ali Al-Odaib; Khaled K Abu-Amero
Journal:  Biomed Res Int       Date:  2015-10-12       Impact factor: 3.411

10.  DNA Methylation at Birth Predicts Intellectual Functioning and Autism Features in Children with Fragile X Syndrome.

Authors:  Claudine M Kraan; Emma K Baker; Marta Arpone; Minh Bui; Ling Ling; Dinusha Gamage; Lesley Bretherton; Carolyn Rogers; Michael J Field; Tiffany L Wotton; David Francis; Matt F Hunter; Jonathan Cohen; David J Amor; David E Godler
Journal:  Int J Mol Sci       Date:  2020-10-19       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.